Ryan Thorpe
MOHS-Micrographic Surgery · Meridian, IDNPI 1568880995
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 205 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 34.2% of the total.
Across 205 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Regeneron Healthcare Solutions, Inc.$476
- Sun Pharmaceutical Industries Inc.$432
- Novartis$327
- Sanofi$223
- UCB, Inc.$112
- plus $802 from 17 others
What the payments were for
- Food & beverage$3,605100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 76 | $1,232 |
| Regeneron Healthcare Solutions, Inc. | 22 | $476 |
| Sun Pharmaceutical Industries Inc. | 25 | $432 |
| Novartis | 26 | $327 |
| Sanofi | 11 | $223 |
| UCB, Inc. | 6 | $112 |
| Boehringer Ingelheim | 4 | $95 |
| Galderma Laboratories, L.p. | 4 | $90 |
| Incyte Corporation | 5 | $88 |
| LEO Pharma Inc. | 4 | $86 |
| Johnson & Johnson | 5 | $78 |
| VYNE Pharmaceuticals Inc. | 1 | $72 |
| Amgen | 3 | $59 |
| Lilly USA, LLC | 2 | $42 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Pierre Fabre Pharmaceuticals, Inc. | 2 | $30 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $28 |
| Nobelpharma America, LLC | 1 | $24 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
| Acera Surgical, Inc. | 1 | $13 |
| Kyowa Kirin, Inc. | 1 | $13 |
| Organon | 1 | $11 |
How this compares
Too few mohs-micrographic surgery providers in Idahoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 66 | $975 |
| Clobetasol Propionate | 18 | $670 |
| Triamcinolone Acetonide | 39 | $555 |
| Mupirocin | 73 | $552 |
| Ketoconazole | 35 | $534 |
| Cephalexin | 29 | $161 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $63 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Meridian
- Daniel WinchesterMeridian$4K
- Peter BoothmanMeridian$2K
- Brandon MinerIdaho Falls$5K
- Earl StoddardChubbuck$3K
- Daniel MarshallRexburg$2K
- David GriffinTwin Falls$789
- Teri CottinghamBoise$149
- Kurtis ReedTwin Falls$32
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.